Latest Syndromes Stories
Northwestern Medicine researchers begin clinical trial to review new treatment for chronic amputee pain CHICAGO, Feb.
Today the Rett Syndrome Research Trust (RSRT) announced research investments of $5.8 million awarded in 2014.
Wimbledon Health Partners supports Marfan Syndrome Awareness Month and its national efforts to promote research, increase awareness and support those dealing with the disease. Boca
Positive statistical correlations were identified between TeaRx(TM) diagnostic parameters and widely used benchmark tests for dry eye syndrome TEL-AVIV, Israel, Feb.
ReportsnReports.com adds “Premenstrual Syndrome - Pipeline Review, H1 2015” to its store.
Product launched new era in proactive dry eye protection, is now going global reports Chairman and fresh water advocate Sharon Kleyne. Grants Pass, OR (PRWEB)
LEXINGTON, Mass., Jan.
LEXINGTON, Massachusetts, January 26, 2015 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that the United States Food and Drug Administration (FDA) has granted
The Visiting Nurse Association of Central Jersey (VNACJ) Ryan White HIV/AIDS medical case management program was again recognized out of a field of sixteen agencies, for excellence in providing
Wimbledon Health Partners' collegiate testing division Wimbledon U delivers on-site diagnostic testing to colleges and universities.
Marfan's syndrome is a genetic disorder of the connective tissue that causes excessively tall stature and long extremities. It is carried by the gene FBN1, which encodes the connective protein fibrillin-1, and is a dominant trait. The human genetic makeup contains a pair of FBN1 genes, so because of its dominance, inheriting one affected FBN1 gene from either parent will result in Marfan's syndrome. It effects both males and females, and has no ethnic bias. It was named after Antoine Marfan,...
- An armed gangster.